The largest database of trusted experimental protocols

123 protocols using panobinostat

1

Cytotoxic Effects of Panobinostat and Romidepsin on Osteosarcoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SAOS2, SAOS2 LM7 and K7M2 cells were seeded 5 × 103 cells per well in 96-well plates and in triplicate were treated with a dose range of panobinostat (Selleckchem, Houston, Texas, Cat #S1030; 1.8, 2.4, 3.3, 4.5, 6.0, 8.1, 11.0, 14.8 and 20 nM) or a dose range of romidepsin (Selleckchem Cat #S3020; 5.9, 8.8 13.2, 19.8, 29.6, 44.4, 66.7, 100 and 150 nM). For dual treatment with panobinostat and Carfilzomib (Selleck Cat #S2853) K7M2 and SAOS2 cells were plated at 5 × 103 cells in 96-well plates and treated with panobinostat at a dose range (1.4, 1.8, 2.5, 3.3, 4.5, 6.1, 8.2, 11.1 and 15 nM) or Carfilzomib at a dose range (1.9, 2.6, 3.5, 4.7, 6.3, 8.5, 11.5, 15.6 and 21 nM) or combination of both drugs. IC50 values were determined at 48 hours posttreatment using cell titer blue assay (Promega, Madison, Wisconsin, Cat # G8080). To determine the tubastatin (Selleckchem Cat # S2627), IC50 value K7M2 cells were seeded at 2 × 104 in 96-well plates and treated with the following concentrations (0, 1, 5, 10, 15, 100, 250, 500, 1250, 2500, 5000 and 10 000 nM). All treatments were done in triplicate and cell growth was assayed at 48 hours using MTS CellTiter 96 cell proliferation assay (Promega Cat # G5421). The impact of panobinostat and romidepsin on PDX derived cell lines was examined in a publicly available dataset (https://braid.stjude.org/masttour/).15 (link)
+ Open protocol
+ Expand
2

Panobinostat Treatment RNAseq Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNAseq was performed as above in SU-DIPG-IV and SU-DIPG-VI cell lines following exposure to 1 µM panobinostat (Selleck Chemicals) for 48 hours. RNAseq was also performed in SU-DIPG-IV, SU-DIPG-VI and JHH-DIPG1 cell lines following exposure to 0.1 µM panobinostat (Selleck Chemicals) for 24 hours in triplicate. Cells were then lysed and RNA extracted in TRIzol solution.
Post-panobinostat RNAseq data analysis: There was a good concordance for the ratio of panobinostat-treated to vehicle-treated cell gene expression and the distribution of RPKM values were similar in both cell lines and with the two conditions. In general, the variability in terms of ratio was low, usually below 1.
+ Open protocol
+ Expand
3

Panobinostat Treatment RNAseq Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNAseq was performed as above in SU-DIPG-IV and SU-DIPG-VI cell lines following exposure to 1 µM panobinostat (Selleck Chemicals) for 48 hours. RNAseq was also performed in SU-DIPG-IV, SU-DIPG-VI and JHH-DIPG1 cell lines following exposure to 0.1 µM panobinostat (Selleck Chemicals) for 24 hours in triplicate. Cells were then lysed and RNA extracted in TRIzol solution.
Post-panobinostat RNAseq data analysis: There was a good concordance for the ratio of panobinostat-treated to vehicle-treated cell gene expression and the distribution of RPKM values were similar in both cell lines and with the two conditions. In general, the variability in terms of ratio was low, usually below 1.
+ Open protocol
+ Expand
4

Panobinostat Treatment for Brain Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon the first appearance of brain tumor symptoms, tumor-bearing mice were treated with either 1) three doses of panobinostat (Selleckchem #S1030) at 10 mg/kg or vehicle (25% DMSO, 0.25x PBS, 5% glucose) administered once daily by i.p. injections (n = 5 in each group), or 2) five doses of panobinostat (Selleckchem) at 20 mg/kg or vehicle administered once daily by i.p. injections (n = 6 in each group). Mice were sacrificed 1 hour after their final treatment via CO2, and their brains were extracted, fixed in 10% formalin, paraffin embedded and sectioned on a microtome. Immunohistochemistry for phospho histone H3 (pH3), cleaved caspase-3 (cc3), and H3 acetylation (AcH3) were conducted with subsequent quantification (described below).
+ Open protocol
+ Expand
5

Murine Xenograft Model of BCP-ALL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Then, 1 × 106 spleen cells from MH/NRASG12D BCP-ALL mice of secondary transplantations were transplanted into sublethally irradiated (450 cGy) recipient mice. The MH/NRASG12D tertiary recipient mice were subjected to the treatment of solvent (as control), 2.5 mg/kg panobinostat (Selleck, S1030), 0.15 mg/kg vincristine (VCR) (Selleck, S1241) plus 1 mg/kg dexamethasone (DEX) (Selleck, S1322), and panobinostat in combination with VCR + DEX, intraperitoneally for 4 cycles of 5-days-on/2-days-off after transplantation. panobinostat was diluted in 2% dimethyl sulfoxide, 48% PEG 300, 2% Tween 80, and double-distilled water. VCR was diluted in double-distilled water. DEX was diluted in 5% dimethyl sulfoxide, 45% PEG 300, and double-distilled water.
More information concerning materials and methods used in this study are described in the supplemental Materials and Methods.
+ Open protocol
+ Expand
6

Epigenetic Modulation in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in a 12-well plate at 7.5 × 105 cells per well 24 h prior to treatments. Cells were treated with 5-aza-2’-deoxycytidine (ADC) (Cat# A3656, Sigma-Aldrich, St. Louis, MO, USA) at indicated concentrations for 96 h, with culture media being replaced every 24 h. Cells were treated with 100 μM Panobinostat (Cat# S1030, SelleckChem, Houston, TX, USA) for 24 h. For the combination experiment, cells were treated with 10 μM ADC for 96 h, with 100 μM Panobinostat added in the last 24 h. On completion of treatments, media was aspirated from culture wells, cells were rinsed with 1× PBS, and frozen at −80 °C until RNA isolation was performed.
+ Open protocol
+ Expand
7

Breast Cancer Cell Culture and Viability Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phenol-red-free DMEMF/12 (PRF-DMEM/F12), charcoal-stripped FBS (CS-FBS), penicillin–streptomycin, GlutaMAX-I, insulin-transferrin-selenium (ITS), Dulbecco’s phosphate-buffered saline (DPBS), TrypLE express, paraformaldehyde (PFA), 4′,6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI), and Cell Tracker™ Green 5-chloromethylfluorescein diacetate (CMFDA) were purchased from Thermo Fisher Scientific, Waltham, MA, USA. Dimethyl sulphoxide (DMSO), Triton X-100, and estradiol-17β (estrogen) were purchased from Sigma-Aldrich, Castle Hill NSW 2154, Australia. The Real Time-Glo™ MT Cell Viability Assay was purchased from Promega, Alexandria NSW 2015, Australia. Salinomycin, panobinostat, fulvestrant, tamoxifen, and Y26732 were purchased from Selleck Chem, Houston, TX 77014 USA.
+ Open protocol
+ Expand
8

Epigenetic modulators in cancer cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug concentrations were as follows except where otherwise specified: GSK-126 (5 μM, Selleckchem, S7061), vorinostat (2 μM, Selleckchem, #S1047), panobinostat (50 nM, Selleckchem, #S1030), MAK683 (5 μM, Selleckchem, S8983), docetaxel (10 nM, Selleckchem, S7787).
+ Open protocol
+ Expand
9

PDOX Mouse Model for Glioblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
In single cell suspension, 100,000 cells were stereotactically injected in the fourth ventricle/pons of. Tumor cells were allowed to engraft for 7 days. Mice were then randomly assigned to a control group where only the vehicle control was administered using intra-peritoneal (i.p) injections, or to one of the three therapeutic groups: 5-azacytidine (Sigma Aldrich, MO; 3 mg/kg diluted in sterile water) daily i.p. injections for five days followed by a two-day rest period every 4 weeks as previously described (Borodovsky et al., 2013 (link); Yamashita et al., 2018 ); panobinostat (Selleck Chemicals, 10mg/kg diluted in DMSO) five days a week alternating with 5 days rest for 4 weeks as previously described (Grasso et al., 2015 ); or a combination of both drugs. For each of the three cell lines used to generate PDOX in mice, nine animals were used for each experimental condition. Mice were then observed until they became moribund, at which point they were sacrificed, and the presence of intracranial tumors was confirmed.
+ Open protocol
+ Expand
10

Apoptosis and Necrosis Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Digitonin, paclitaxel, calcium chloride, 0.4% trypan blue, dimethyl sulfoxide and 7-AAD were purchased from Sigma-Aldrich. Panobinostat and bortezomib were sourced from Selleckchem. rhTRAIL was purchased from Gibco and staurosporine obtained from LC Laboratories. The Alexa Fluor® 488 Annexin V/Dead Cell Apoptosis Kit was purchased from Thermo-Fisher. Caspase-Glo®-3/7 Assay, Digitonin solution and NanoGlo® Luciferase Assay Substrate were obtained from Promega. The pro-furimazine NanoBiT™ substrate (endurazine) and a novel asymmetric cyanine dye, Necrosis Detection Reagent, were synthesized and purified by Promega Biosciences, LLC.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!